Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure - Wikidata - awgldk - TriplyDB

Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure

Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure

http://www.wikidata.org/entity/Q27316203

about

Inhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct versus Indirect Mechanisms Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging Molecules Resveratrol and Cardiovascular Diseases Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases Mitochondria as a therapeutic target in heart failure Experimental studies of the molecular pathways regulated by exercise and resveratrol in heart, skeletal muscle and the vasculature Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress The role of sirtuins in cardiac disease A cardiac-specific robotized cellular assay identified families of human ligands as inducers of PGC-1α expression and mitochondrial biogenesis Resveratrol inhibits the epithelial sodium channel via phopshoinositides and AMP-activated protein kinase in kidney collecting duct cells Measurement of technetium-99m sestamibi signals in rats administered a mitochondrial uncoupler and in a rat model of heart failure Longitudinal in vivo SPECT/CT imaging reveals morphological changes and cardiopulmonary apoptosis in a rodent model of pulmonary arterial hypertension Protective effect of resveratrol against pressure overload-induced heart failure.Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.Resveratrol increases nitric oxide production in the rat thick ascending limb via Ca2+/calmodulin Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca(2+) cycling proteins.High intensity interval and endurance training have opposing effects on markers of heart failure and cardiac remodeling in hypertensive rats.Emerging beneficial roles of sirtuins in heart failure.Polyphenols: benefits to the cardiovascular system in health and in aging Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.Oxidative stress and cardiovascular health: therapeutic potential of polyphenols.Polyphenol Conjugates and Human Health: A Perspective Review.Effects of resveratrol and nebivolol on isolated vascular and cardiac tissues from young rats.Mitochondrial injury and dysfunction in hypertension-induced cardiac damage.Therapeutic potential of resveratrol in heart failure.Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.Resveratrol and exercise.Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation.Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts.High-intensity interval and endurance training are associated with divergent skeletal muscle adaptations in a rodent model of hypertension.Resveratrol prevents pathological but not physiological cardiac hypertrophy.Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart.Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats.Submaximal ADP-stimulated respiration is impaired in ZDF rats and recovered by resveratrol.Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure

P2860

Q21296696-E66A5915-77B5-4137-A6E2-30D3293EA7F1 Q24618313-39FE3CF8-27FD-4298-88A5-0DF2BB0817E7 Q26747742-DE3649B6-23FD-4B7B-947B-24BCD065C1AE Q26752801-2B8B8231-87D5-4690-9DA0-D31674CBB5C0 Q26778562-B4B08637-FF7C-4E95-A338-DA478F226D6D Q26800907-AF06BD3D-0D1E-4406-8B8D-519D70AE8B5D Q26999376-33E84D8D-F3D8-421B-963B-40DCF7281395 Q27002456-B766698E-73D2-43AA-A1E0-722F50ACACCD Q27005632-52FC1609-0030-41CC-9487-2E00F39BB5C9 Q27016095-ED12069F-3B54-4470-9CA5-AEA2BFAD82BB Q27025057-4DC56598-1E8F-465A-AC21-7D791ADEAB43 Q27693274-AB0AA5F8-0D5D-4E35-9CC8-E0BF9DFF7D14 Q28484191-9E17DB46-ED4B-4DF5-A830-6870DD0EC615 Q28534677-CD8F811B-60E7-4A36-8552-1C3B7F854B83 Q28543037-EAECBEF0-E63F-491F-8795-8B895C3B131A Q28729124-2C93248E-3263-4E16-8088-7BAC9FB6BE3B Q33723046-A8887A1A-68FE-40E8-9F2B-9F1A351EB714 Q33976440-0AB20DCC-FE6D-476B-8C2D-4CB6944B1945 Q34338591-C2B9B335-D62E-4789-924C-04787FFC365D Q34782924-71BA08B5-3DE1-4122-8657-CA8F6370C97B Q35214333-1BE21E7A-AD43-45C8-8393-6FDE7EF559C9 Q36078945-9B37820D-DD91-445D-A649-46A7DB1B6C27 Q37286692-F71ADD73-BA42-4D53-BBDF-2C8E10D48A14 Q38054603-0419DC5D-5414-4D87-8533-1CEFC94AC73F Q38093866-00FD5751-65CE-44A3-80F1-22D3A4411AF3 Q38215429-1BF2BBD9-B9C7-43AE-A226-6236F64F1251 Q38256443-0E3A8EE3-3C5C-4DA7-9556-9DBB4AEF3117 Q38266758-283E788E-B135-4E91-B18D-09354D3A4216 Q38552981-C3CF628B-D36E-4D5D-A064-BA107AC54BBE Q38979963-EF4CDD30-A87F-41ED-8A50-5F38CEDBCD33 Q39018525-2166CA85-DA69-46DB-81BC-9657266B365E Q40286144-193376D7-878A-45FA-8DBB-91B809877256 Q40528109-815BD2E7-AF8F-4426-8540-B521D9BA3620 Q41099304-0C8FFED2-6C17-4E1C-B8C7-56E94D485545 Q42703628-0954EB1A-5E75-49D3-BCB5-A1143A09A545 Q44050017-92E320D7-C6B0-4602-86D2-34D13C8AAD73 Q46472199-960E20D8-3538-4546-A6FA-E8CE6D5C7FC5 Q46872133-BE18DBA3-2C0E-487F-9FDF-D1B8E45A450E Q58766782-11AE7AFB-8CB7-4FF3-BCD4-6C0484AA1BB4

P2860

Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure

http://www.wikidata.org/entity/Q27316203

description

2011 nî lūn-bûn

@nan

2011 թուականին հրատարակուած գիտական յօդուած

@hyw

2011 թվականին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Resveratrol improves survival, ...... nsion leading to heart failure

@ast

Resveratrol improves survival, ...... nsion leading to heart failure

@en

Resveratrol improves survival, ...... nsion leading to heart failure

@nl

type

label

Resveratrol improves survival, ...... nsion leading to heart failure

@ast

Resveratrol improves survival, ...... nsion leading to heart failure

@en

Resveratrol improves survival, ...... nsion leading to heart failure

@nl

prefLabel

Resveratrol improves survival, ...... nsion leading to heart failure

@ast

Resveratrol improves survival, ...... nsion leading to heart failure

@en

Resveratrol improves survival, ...... nsion leading to heart failure

@nl

P1433

Q27316203-7A09D7DE-7AB3-4B10-9334-CAB4ABD46D65

P1476

Q27316203-D1B9AB2E-82E3-48D5-84BE-2479797F727D

P2093

Q27316203-04655590-B81B-492E-87C0-7849D5CEC7A5

Q27316203-21B91625-B430-427A-A603-59A08A7F7661

Q27316203-61ABFF38-BF8C-4344-9714-EA96F9D5DE16

Q27316203-C87451E5-3CEA-41AC-9F99-5B6361221E3D

P2860

Q27316203-07809A75-2BF3-4B87-966F-F1848E0B6EC7

Q27316203-0AE4B1C3-B5EC-4DD2-8A94-24695ED67B88

Q27316203-0E28B669-1998-4BC4-8F24-0DA63894C139

Q27316203-0EDEFAAE-1DB5-4910-9DF1-E280F3DDCD9D

Q27316203-213E120B-4D3F-41D7-BBB3-BF6A95686D02

Q27316203-2397B569-F473-433C-AB65-4C7F11BD2C8A

Q27316203-2D4D0702-7074-4731-920F-C36C15C69E6D

Q27316203-30F6CDB0-8FC1-4219-B5B8-84412952ABE4

Q27316203-32DEFFB6-F6A8-4A4B-BA89-558E9EF6BB50

Q27316203-36707DFB-7C36-4381-924F-31BF3594E89E

P304

Q27316203-7FD83D85-64FB-4174-BBBD-20B53C6D5F47

P31

Q27316203-AF5108F7-F1CE-4C9B-AD30-EBFF22F487E7

P3181

Q27316203-F3C3FDB1-FC62-4368-B27F-EFCCEE7A519A

P356

Q27316203-EC2F182E-361E-43E4-A3DD-741EF31FC468

P407

Q27316203-83E3D762-B38E-484C-8AAA-20CC4FAECBA8

P433

Q27316203-2891D66D-2E18-4D5B-BEB6-C4300907FB01

P478

Q27316203-3DE9AB44-EDD1-4AA2-84C0-EFD1D1F430A6

P50

Q27316203-450A0587-2880-41BA-B4F4-22BACE47B347

Q27316203-BD582000-1F48-4F9E-BC64-96DC2FB99187

Q27316203-C4607632-2443-45E6-9EA9-94595B2B791E

Q27316203-DAB57642-8648-4549-8C2B-BDCBE47C1305

P577

Q27316203-D48CEF30-F9EC-43DB-B3F3-4B520B550FB9

P5875

Q27316203-E20F975D-C289-408C-BEB9-E2FE31444CB4

P698

Q27316203-647AF8CB-735F-4C01-8BFD-480FB18E5F99

P921

Q27316203-267F8485-70CD-4864-B39A-5EBF6B6D2773

Q27316203-711471F1-6649-478D-A09C-8BA1382ADC5C

Q27316203-8FCE0D97-9B8F-4E1B-8576-46C76E63595C

P932

Q27316203-3626D89E-754C-4E24-AF25-CA2D8CBA49BD

P3181

P356

JOURNAL.PONE.0026391

P1433

P1476

Resveratrol improves survival, ...... nsion leading to heart failure

@en

P2093

Dominique Fortin

http://www.w3.org/2001/XMLSchema#string

Matthieu Ruiz

http://www.w3.org/2001/XMLSchema#string

Philippe Mateo

http://www.w3.org/2001/XMLSchema#string

Stéphanie Rimbaud

http://www.w3.org/2001/XMLSchema#string

P2860

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha

Differential effects of thyroid hormones on energy metabolism of rat slow- and fast-twitch muscles

The failing heart--an engine out of fuel

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

Whole grape intake impacts cardiac peroxisome proliferator-activated receptor and nuclear factor kappaB activity and cytokine expression in rats with diastolic dysfunction.

Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.

Mitochondrial fusion and fission in mammals.

Sirtuins: novel targets for metabolic disease.

Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha.

P304

e26391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4861027

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0026391

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Vladimir Veksler

Jérôme Piquereau

Renée Ventura-Clapier

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51746793

http://www.w3.org/2001/XMLSchema#string

P698

22028869

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3196575

http://www.w3.org/2001/XMLSchema#string